WI Harper Group-backed XWPharma Raises $40 Million Series C Financing

WI Harper Group | September 17, 2020 | Source: XWPharma WI Harper-backed XWPharma (formerly XW Laboratories), a biopharmaceutical company dedicated to the discovery and development of therapeutics that apply platform chemistry to time-regulated neurobiology, today announced it completed a $40 million Series C financing. The financing was led by Panacea Venture, with participation from existing…